Detection of a ~ 100 kD protein with strong immunoreactivity to antibodies specific for inducible nitric oxide synthase (iNOS) but without NOS activity in neutrophils of patients suffering from sepsis: Results of a preliminary study

Inflammation Research

Volumn 48, Issue 12, 1999, Pages 651-656

  Richter, N ^a   Petersson, A S ^b   Wennmalm, A ^b   Schimke, I ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Human neutrophils; Inducible nitric oxide synthase; Nitric oxide; Sepsis

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRATE; NOS2 PROTEIN, RAT; NOS2A PROTEIN, HUMAN; PROTEIN; ZYMOSAN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; LEUKOCYTE ACTIVATION; NEUTROPHIL; PROTEIN EXPRESSION; SEPSIS; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKOCYTE; METABOLISM; RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; NEUTROPHILS; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTEINS; RATS; SEPSIS; ZYMOSAN;

EID: 0033257037     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050517     Document Type: Article

References (21)

1. [1] Hamers MN, Ross D. Oxidative stress in human neutrophil granulocytes: host defence and self-defence. In: Siess H, editor. Oxidative stress. New York: Academic Press, 1985: 351-81.
2. [2] Beckman JS. The pathophysiology and pathological chemistry of nitric oxide. In: Lancaster J, editor. Nitric oxide: Principles and actions. New York: Academic Press, 1996: 1-82.
3. [3] Miles AM, Owens MW, Milligan S, Johnson GG, Fiels JZ, Ing TS, et al. Nitric oxide synthase in circulating vs. extravasated polymorph nuclear leukocytes. J Leuk Biol 1995; 58: 616-22.
4. [4] Evans TJ, Buttery LDK, Carpenter A, Springall DR, Polak JM, Cohen J. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc Natl Acad Sci USA 1996; 93: 9553-8.
5. [5] Wheeler AM, Smith SD, Garcia-Cardena G, Nathan CF, Weiss RM, Sessa WC. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 1997; 99: 110-6.
6. [6] Yan L, Vandivier RW, Suffredini AF, Danner RL. Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity. J Immunol 1994; 153: 1825-34.
7. [7] Wallerath T, Gath I, Autlitzky WE, Pollock JS, Kleinen H, Förstermann U. Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thromb Haemost 1997; 77: 163-7.
8. [8] Barriere SL, Lowry SF. An overview of mortality risk prediction in sepsis. Crit Care Med 1995; 23: 376-96.
9. [9] Griffith OW, Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanisms. Annu Rev Physiol 1995; 57: 707-36.
10. [10] Ochoa JB, Udekwu A, Billiar TR, Curran RD, Cerra FB, Simmons RL, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214: 621-6.
11. [11] Wong HR, Carcillo JA, Burckart G, Shah N, Janosky JE. Increased scrum nitrite and nitrate concentrations in children with the sepsis syndrome. Crit Care Med 1995; 23: 835-42.
12. [12] Goode HF, Howdle PD, Walker BE, Webster NR. Nitic oxide synthase activity is increased in patients with sepsis syndrome Clin Sci 1995; 88: 131-3.
13. [13] Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA. Definitions for sepsis and organe failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Chest 1992; 101: 1644-55.
14. [14] Danner RL, Joiner KA, Parillo JE. Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Azalipid X. J Clin Invest 1987; 80: 605-12.
15. [15] Ringgvist A, Leppert J, Myrdal U, Ahlner J, Ringgvist I, Wennmalm A. Plasma nitric oxide metabolite in woman with primary Raynand's phenomenon and in healthy subjects. Clin Physiol 1997; 17: 269-77.
16. [16] Griscavage JM, Rogers NE, Sherman MP, Ignarro L.J. Inducible nitric oxide synthase from rat alveolar macrophage cell line is inhibited by nitric oxide. J Immunol 1993; 151: 6329-37.
17. [17] Wright CD, Mülsch A, Busse R, Osswald H. Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 1989; 160: 813-9.
18. [18] Hevel JM, White KA, Marletta MA. Purification of the inducible murine macrophage nitric oxide synthase. J Biol Chem 1991; 266: 22789-91.
19. [19] Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of inducible nitric oxide synthase from murine macrophage cell line. J Biol Chem 1992; 267: 6370-74
20. [20] Kozak M. Analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987; 5: 8125-48.
21. [21] Xie Q-W, Cho H J, Calaycay J, Mumford RA, Swiderek KM, Lee TD, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225-8.